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Abstract 
Pseudorabies virus (PrV) belongs to the α‑herpesvirinae of which human simplex virus (HSV) is the prototype virus. 
One of the hallmarks of HSV infection is shutoff of protein synthesis that is mediated by various viral proteins includ‑
ing vhs (virion host shutoff ), which is encoded by the UL41 gene. However, the function of PrV vhs is poorly under‑
stood. Due to the low sequence similarity (39.3%) between the HSV and PrV UL41 proteins, vhs might not share the 
same biochemistry characteristics. The purpose of this study was to characterize the nuclease activity of the PrV vhs 
protein with respect to substrate specificity, its requirements in terms of cofactors, and the protein regions, as well 
as key amino acids, which contribute to vhs activity. Our results indicated that, similar to HSV vhs, PrV vhs is able to 
degrade ssRNA and mRNA. However, PrV vhs also targeted rRNA for degradation, which is novel compared to the 
HSV‑1 vhs. Activity assays indicated that Mg2+ alone enhances RNA degradation mediated by PrV vhs, while K+ and 
ATP are not sufficient to induce activity. Finally, we demonstrated that each of the four highly conserved functional 
boxes of PrV vhs contributes to RNA degradation and that, in particular, residues 152, 169, 171, 172, 173 343, 345, 352 
and 356, which are conserved among α‑herpesviruses, are key amino acids needed for PrV vhs ribonuclease activity.
© 2015 Liu et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Pseudorabies virus (PrV), an enveloped dsDNA virus 
belonging to the α-herpesvirinae, causes Aujeszky’s dis-
ease of swine [1]. Similar to the herpes simplex virus 
type 1 (HSV-1), the prototype virus of α-herpesviruses, 
the PrV tegument contains the virion host shutoff (vhs) 
protein, which is encoded by the UL41 gene [2]. HSV 
vhs has ribonuclease activity that produces a reduc-
tion in overall protein synthesis via mRNA degradation; 
this effect on the cellular translational apparatus is ben-
eficial in terms of viral protein synthesis [3]. In addition 
to cellular mRNA, vhs also degrades viral RNAs, which 
facilitates a sharpening of the transitions between the 
successive phases of viral protein synthesis [3]. Moreover, 
in a mouse model, replication of a vhs-deficient HSV-1 
was found to be significantly attenuated and this was cor-
related with the degradation of cytokine mRNAs, includ-
ing type I IFN and IL-8 [4]. It has also been reported that 
vhs is responsible for a reduction in components of major 
histocompatibility complex class I in cells infected with 
HSV-2. These findings indicate that vhs-dependent ribo-
nuclease activity is important to HSV virulence [5].
The mechanism of vhs-induced ribonuclease activity 
by HSV-1 has been intensively studied. Initially, the ribo-
nuclease activity of vhs was identified in HSV-1infected 
cells [3], and its substrate specificity was further char-
acterized using an in  vitro assay system that consisted 
of HSV-1 infected cell lysate [3, 6, 7]. Subsequently, the 
protein’s endonuclease activity was explored using vhs 
protein that had been translated using a variety of differ-
ent systems, including rabbit reticulocyte lysate (RRL) [8] 
and the budding yeast Saccharomyces cerevisiae [9]. Vhs 
translated using RRL induced degradation of a variety of 
RNAs including ssRNA and mRNA with a 5′ cap and a 
3′poly (A) tail [8]. Furthermore, it was demonstrated that 
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vhs preferentially targets regions adjacent to the transla-
tion initiation sites of mRNAs, for example the 5′ end of 
the RNA [10], or the 3′-flanking sequences of the inter-
nal ribosome entry sites (IRES) of encephalomyocarditis 
virus (EMCV) and poliovirus [8]. Moreover, mamma-
lian cellular factors were found to increase overall RNase 
activity, as well as inducing the preferential cleavage of 
HSV-1 vhs produced using the Saccharomyces cerevisiae 
system at particular sites [9]. It was further demonstrated 
by other research groups that there was an association of 
vhs with components of the cap-binding complex eIF4F, 
including eIF4H, eIF4A, and eIF4B; this was found to 
be responsible for the specific targeting pattern of vhs 
[11–13].
In 1991, using a cytoplasmic extracts from HSV-1-in-
fected HeLa cells, Krikorian and Read revealed that vhs-
mediated RNase activity was not inhibited by RNase 
inhibitor; however it was found to be strongly depend-
ent on presence of divalent cations such as Mg2+, but did 
nor require energy components such as ATP or GTP [7]. 
However, it was influenced by K+; efficient vhs-induced 
degradation of RNA occurs at the concentration of K+ 
up to 200 mM, but not when the concentration is higher 
than 500  mM. The requirement of Mg2+ was also con-
firmed using an assay based on vhs translated by RRL 
[8]. Although ATP is not essential for vhs activity, it is 
required for optimal vhs mediated RNA degradation in 
the presence of Mg2+.
HSV-1 vhs targets mRNA, but spares rRNA and tRNA 
from degradation [3, 6, 7]. Sequence analysis has indi-
cated that vhs shares similarity with RNase H, which is 
able to degrade ssRNA from DNA/RNA hybrids, and 
with cellular nucleases of the FEN-1 family that shows 
exo/endonuclease activity with RNA and DNA substrates 
[14]. However, the RNase activity of vhs, in general, has 
been tested only using ssRNA, and whether vhs has bio-
activity, particularly substrate specificity resembling 
RNase H or FEN-1, remains unclear.
Based on sequence alignments analysis, the vhs protein 
has been found to be conserved across many members of 
α-herpesviruses, including, HSV-1, HSV-2, varicella zos-
ter virus (VZV), PrV, and equine herpesvirus (EHV-1) 
[15]. Notably, there are four deduced functional regions, 
namely Boxes I–IV, present in PrV vhs (Figure  1). Lin 
et al. demonstrated that PrV vhs is involved in virion host 
shut off of protein synthesis and also contributes to PrV 
virulence in a mouse model [13]. In addition, the ribonu-
clease activity of PrV vhs was initially identified using an 
in vitro system where the purified recombinant vhs pro-
tein was fused with thioredoxin and found to be able to 
degrade ssRNA markers [16]. However, up to the present, 
the mechanism of action of vhs remains largely unknown. 
Taking into consideration the low similarity found when 
the vhs protein sequences of PrV and HSV-1 are com-
pared (39.3%), these two vhs orthologs might not share 
the same characteristics. Thus the biochemical character-
istics of PrV vhs, including the enzyme’s substrate speci-
ficity, its requirements in terms of catalytic factors (Mg2+, 
K+ or ATP), the types of nucleic acid it prefers to degrade 
and the key residues involved in the vhs-dependent ribo-
nuclease activity, were explored in this study using sys-




Human embryonic kidney 293T (HEK293T) cells was 
propagated in Dulbecco’s Modified Eagle Medium 
(DMEM, Gibco BRL, Life Technologies Corporation, 
Carlsbad, CA, USA) containing 10% bovine fetal calf 
serum (Hyclone, Logan, UT, USA) and 1% of penicillin–
streptomycin (Gibco, BRL). Cells were cultured at 37 °C 
in a 5% CO2 atmosphere.
Sequence alignment of the vhs proteins of α‑herpesviruses 
and other ribonuclease
The amino acid sequences of HSV-1 (accession num-
ber CAA96525), HSV-2 (AEV91380.1), and PrV 
(AID18742.1) vhs were aligned by the DNASTAR Soft-
ware MegAlign (DNASTAR, Inc. Madison, Wisconsin, 
USA).
Construction of plasmids expressing various vhs proteins
To generate the recombinant vhs proteins for in  vitro 
assay, wild type PrV vhs coding region was constructed 
in vector pET44a (+) (Novagen, Germany) in two steps. 
Initially, nus fragment with deletion of the two hexa-
histidine (6-His) sequences in front and rear ends of 
nus-coding region was amplified from pET44a (+) by 
polymerase chain reaction (PCR) using the primer sets 
(NdeI-Nus-F: GGCATATGAACAAAGAAATTTTGGC 
TGT and SacII-Nus-R: ACCCGCGGACGCTTCGTC 
ACCGAACCAGCA). For the ease of further clon-
ing, all the primer sets contain sequences of restric-
tion enzyme sites, shown as underlined. The thermal 
cycling conditions were: 94  °C (5  min) followed by 35 
cycles of denaturation (94  °C, 1  min), annealing (55  °C, 
1  min), and extension (72  °C, 2  min), and finished with 
a final extension (72  °C, 7  min). The PCR product with 
expected size of 1.6 kilo base pairs (kb) was purified and 
digested with NdeI and SacII restriction enzymes. Modi-
fied nus fragment was then cloned into vector pET44a 
(+) to replace the original 6-His nus sequences; the 
resulting plasmid was named pET44a (∆his-tag). Subse-
quently, PrV vhs gene amplified from the genome of PrV 
TNL strain [19] by PCR using the primer sets (PrV-F: 
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AAGGATCCGCCATGGGGCTCTTTGGCCTTT 
and PrV-R: AACTCGAGTTATTTTCTCCTGTGGG) 
was inserted into pET44a (∆his-tag) vector linear-
lied with BamHI and XhoI; the resulting plasmid was 
named pET44-PrV vhs. The plasmid map is presented in 
Figure 2A.
To characterize the function of vhs protein in mam-
malian cells, eukaryotic plasmids expressing vhs proteins 
of PrV or HSV-1 were constructed. Initially, HSV-1 vhs 
coding region was amplified by PCR using the primer 
set (HSV1-F: AAAAAGCTTATGGGTTTGTTCGGG 
ATGAT and HSV1-R: AACTCGAGCTACTCGTCCCA 
GAATTTGGCC) from HSV-1 KOS strain (a gift from 
Professor S. H. Chen, Department of Microbiology and 
Immunology of National Cheng Kung University, Tai-
wan). The resulting PCR product (1.5  kb) was digested 
with HindIII and XhoI restriction enzymes, which are 
present in the primers, and then was subcloned into the 
expression vector pcDNA3.1(+) (Invitrogen, Carlsbad, 
CA, USA). As for PrV vhs, the vhs fragment (1.1  kb) 
obtained from pET44-PrV vhs plasmid digested with 
BamHI and XhoI restriction enzymes was subcloned 
into vector pcDNA3.1(+). Plasmid expressing HSV-1 
vhs and PrV vhs were designated as pcDNA3.1/HSV vhs, 
pcDNA3.1/PrV vhs, respectively.
In addition, a series of plasmids bearing PrV vhs muta-
tions were generated. Based on the sequence alignment, 
four highly conserved motifs (Box I–IV) and several key 
residues contributed to vhs mediated shutoff of pro-
tein synthesis among α-herpesviruses were deducted 
(Figure  1). To evaluate the contribution of each indi-
vidual functional motifs, PrV vhs fragment with dele-
tion of one of the four deduced boxes (∆Box I–IV) was 
generated by PCR. ∆Box I of vhs fragment was ampli-
fied by PCR using Pfu DNA polymerase (NEB, NEW 
ENGLAND BioLabs® INC.) and primer sets with built-
in sequences of BamHI/XhoI as shown in underlines 
(Box  1–F: AAGGATCCGCCATGGAGAAGCACTAC 
and PrV-R: AACTCGAGTTATTTTCTCCTGTGGG). 
The PCR condition were 94  °C (7  min) followed by 35 
cycles of denaturation (94  °C, 45  s), annealing (55  °C, 
50 s), and extension 68 °C (1 min 30 s), and finished with 
a final extension (68  °C, 7  min). ∆Box II or ∆Box III of 
vhs fragment were generated using a PCR-driven over-
lap extension method [20]. First, to amplify the 5′ arm 
sequence of ∆Box II vhs by primer PrV-F (AAGGA 
TCCGCCATGGGGCTCTTTGGCCTTT) and Box2- 
R (CATGATGGCCTTGGCCGTGGTCGCGTTGTC). 
In addition, 3′ arm of PrV vhs Box II was ampli-
fied with primer Box2-F (GACAACGCGACCACG 
Figure 1 Sequence alignment of the vhs coding regions. The vhs sequences of HSV‑1, HSV‑2, and PRV were analysed by DNA Star MegaAlign 
software. Identical residues are denoted as “.” and deleted amino acids are indicate as “‑”. Four conserved region, designated as Boxes I–IV (reported 
in Berthomme et al. [15]) are marked. In addition, several deduced residues, numbered according to the PrV vhs gene, that have been reported as 
being responsible for ribonuclease activities are indicated with arrowheads.
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GCCAAGGCCATCATG) and PrV-R. Subsequently, 
these two PCR fragments was served as template for the 
sequel PCR amplification using outer primer set (PrV-F/
PrV-R) for amplifying ∆Box II vhs fragment. Similarly, 
∆Box III of vhs fragment was amplified by this 2-step PCR 
with primer sets (PrV-F/Box3-R (CTCCAGCGACTCG 
GCCGGCGCGTGCAGCAT), Box3-F (ATGCTGCAC 
GCGCCGGCCGAGTCGCTGGAG)/PrV-R, and the 
resulting amplicons were then used as template for the 
second run PCR using primer set PrV-F/PrV-R. The 
Box IV is located at very 3′-end of PrV vhs gene; ∆Box 
IV of vhs fragment was generated by PCR using forward 
primer PrV-F and a degenerated reverse primer Box4-R 
(AACTCGAGTTATTTTCTCCTGTGGGCGTTACA 
GTCGTCTATGTGCTTCCAAAAC) containing the 
remnant 3′ termini of vhs sequences. All the products 
were digested with two enzymes (BamHI and XhoI) 
and then cloned into pcDNA3.1(+) vector linearlized 
with the same enzymes. The authenticity of the plas-
mids (pcDNA3.1/PrV vhs ∆Box I, II, III, IV) was deter-
mined by automatic sequencing (Mission Biotech, Taipei, 
Taiwan).
In addition, the QuikChange™ site-directed mutagen-
esis system (Stratagene, California, USA) was used to 
substitute the individual fourteen conserved residues (at 
amino acid 34, 81, 95, 150, 152, 169, 171, 172, 173, 219, 
343, 345, 352 and 356) to Alanine following the manu-
facturer’s procedure. The sequence of mutagenic primers 
was listed in Table  1. The PCR amplification conditions 
were 95 °C for 5 min followed by 18 cycles of denatura-
tion at 95 °C for 30 s, annealing at 60 °C for 1 min, DNA 
extension at 68 °C for 8 min and a final extension at 68 °C 
for 7  min. All amplification cycles were performed in a 
DNA thermal cycle (GeneAmp PCR system 2700) and 
the PCR product was then treated with Dpn I, followed 
by transformation into the XL1-Blue competent cells. 
The plasmid with expected mutation sequences was 
determined by automated DNA Sequencing (Mission 
Biotech, Taipei, Taiwan).
Preparation of purified PrV NUS‑vhs recombinant proteins
Plasmids expressing PrV vhs fused with NUS tag pro-
tein at N-terminus end and 6-histidine tag at C-ter-
minus end was transformed into Escherichia coli (E. 
Figure 2 Expression and purification of recombinant PrV vhs protein using E. coli. The coding region of PrV vhs was inserted downstream 
of the NUS gene in pET44 vector (A). In this expression system, the recombinant vhs protein was fused with NUS tag protein and a his tag at the N 
and C terminus, respectively. Under IPTG induction, NUS‑vhs‑his with a predicted molecular weight of ~110 kDa was expressed (B, lane 2) and then 
purified using Ni–NTA beads (lane 3). Subsequently, the N‑terminal NUS tag was removed by thrombin treatment (lane 4). M protein marker; Lane 1 
non‑induction lysate. The identity of the PrV vhs was initially confirmed by Western blot analysis using antibodies against the his tag (C). The arrow 
indicates the uncleaved NUS‑vhs‑his recombinant protein, and the thin arrowheads indicate the NUS tag and vhs‑his after thrombin digestion. The 
ribonuclease activity of PrV vhs was tested using single stranded RNA (D). RNA substrates generated by in vitro transcription were incubated with 
assay buffer (mock), NUS protein (as a negative control), or recombinant PrV vhs protein for the indicated times (0, 10, 20, 40, and 60 min). The RNA 
reaction products were then analyzed by 1.3% agarose‑formaldehyde gel electrophoresis and the amount of RNA remaining was measured by 
imageJ system. The experiment was repeated three times and the RNA content at the time point of 0 h was set to 100% (E).
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coli) strain BL21. Expression of all the recombinant 
proteins was induced by 0.8  mM of isopropyl β-d-1-
thiogalactopyranoside (IPTG) and further purified by 
the chelating Sepharose Fast Flow (GE Healthcare) fol-
lowing the method described in one previous study [21]. 
Purity of recombinant proteins was initially confirmed 
by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) and the concentration of recombi-
nant proteins was estimated by comparing with the band 
intensity of known concentration of bovine serum albu-
min (BSA) quantified by National Institutes of Health 
ImageJ software version 1.43 [22].
To remove the NUS protein tag from vhs, proteo-
lytic cleavage was conducted using biotinylated throm-
bin kit (Novagen, Germany) following manufacturer’s 
instructions. Briefly, 400  μg recombinant proteins was 
incubated with 0.5 U biotinylated thrombin, 50  μL 
10× thrombin cleavage buffer (200  mM Tris–HCl, pH 
8.4, 1.5  M NaCl, 25  mM CaCl2) at 20  °C for 4  h. After 
cleavage reaction, biotinylated thrombin was removed 
by chromatography using streptavidin agarose beads (8 
μL), and the flow through solution containing vhs was 
collected. Finally, the recombinant protein was dialyzed 
against vhs assay buffer (1.6  mM Tris acetate, 80  mM 
potassium acetate, 2  mM magnesium acetate, 0.1  mM 
DTT, 0.25 mM ATP, pH 7.8) at 4 °C to remove the excess 
imidazole. The protein concentration was estimated by 
SDS-PAGE using the standard curve of known concen-
trations of BSA.
Western blot analysis
Proteins resolved on 10% SDS-PAGE were further trans-
ferred to nitrocellulose membrane using Mini Protein III 
equipment (Bio-Rad Laboratories, Richmond, CA, USA) 
for Western blot analysis. After blocking with phosphate-
buffered saline with tween® 20 (PBST) containing 5% 
skimmed milk for 1  h at room temperature. Membrane 
was incubated with 1:2000 diluted anti-His tag anti-
body (AbD Serotec., Kidlington, UK) in 5% skimmed 
milk at 4 °C for overnight. After washes with PBS-T (PBS 
containing 0.1% tween 20) buffer, the filter was then 
incubated with 1:10 000 diluted secondary antibody, goat 
anti-mouse IgG conjugated HRP (Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA, USA), for 
1  h at room temperature. After several times of PBS-T 
washes to remove the unbound antibodies, the signal was 
Table 1 Oligonucleotides used for construction of PrV vhs bearing point mutations in this study.



















172(delete ACG) (F) 5′‑GTGCACACGACGGAC-GACATGATCCTCACC‑3′
(R) 5′‑GGTGAGGATCATGTCGTCCGTCGTGTGCAC‑3′
343(delete CCC) (F) 5′‑TTTTGGAAACACATA-CCGCCCCCGAACTAC‑3′
(R) 5′‑GTAGTTCGGGGGCGGTATGTGTTTCCAAAA‑3′
345(delete CCC) (F) 5′‑AAACACATACCCCCG-CCGAACTACCAGGCC‑3′
(R) 5′‑GGCCTGGTAGTTCGGCGGGGGTATGTGTTT‑3′
352(delete TCC) (F) 5′‑AACTACCAGGCCGTC-ATGGCGTACTGGGAC‑3′
(R) 5′‑GTCCCAGTACGCCATGACGGCCTGGTAGTT‑3′
356(delete TGG) (F) 5′‑GTCCTCATGGCGTAC-GACGACTGTAACGCC‑3′
(R) 5′‑GGCGTTACAGTCGTCGTACGCCATGAGGAC‑3′
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detected by TMB reagent (KPL, Kirkegaard and Perry 
Laboratories, Inc., Gaithersburg, MD, USA).
In vitro translation of vhs proteins
DNA (2 μg) of plasmids pcDNA3.1/HSV vhs or 
pcDNA3.1/PrV vhs were individually added into a 40 μL 
rabbit reticular lysate (RRL; TNT® T7 Quick coupled 
Translation system, Promega, Madison, WI, USA) reac-
tion mixture containing 20 μCi of [S35] methionine. 
Translation reactions were carried out at 30 °C for 1.5 h. 
The translation reaction products were confirmed with 
10% SDS-PAGE and autoradiography.
Preparation of various assay substrates for in vitro vhs 
assay
Different kinds of nucleic acid substrates, including 
DNA, RNA, and RNA/DNA hybrid, were used in this 
study. RNA substrates, including ssRNA, or ssRNA with 
cap and polyA tail (mRNA), and rRNA were generated as 
follows:
First of all, the template for transcribing control ss 
RNA was generated by digestion of SP6LUC plasmid 
(Promega) with Xmn I followed by in vitro transcription 
by SP6 RNA polymerase. After purifying with phenol/
chloroform, RNA were further treated with RNase-free 
DNase (Promega, Madison, WI, USA) at 30  °C for 1  h 
to remove DNA template. The template for mRNA tran-
scription was generated from pcDNA3.1-MV-LUC plas-
mid by PCR using forward primer containing upstream 
sequences of T7 promoter and the reverse primer con-
taining a 21-nucleotide polyA 3′ overhang [23]. The PCR 
products were purified and transcribed by T7 RNA poly-
merase (Promega) in the presence of mono-methylated 
cap analog m7G5′-pppp-G (Epicentre, Madison, WI, 
USA). The rRNA was extracted from transfected 293T 
cells using Trizol® reagent (Invitrogen) following the 
manufacturer’s instruction. The ssRNA was resolved on 
a 1.3% formaldehyde denatures agarose gel and the con-
centration was calculated by spectrophotometer (GE 
NanoVue).
Several of DNA substrates were prepared for vhs assay, 
including M13KE phage single stranded DNA (ssDNA) 
obtained from NEW ENGLAND BioLabs® INC and 
uncut double stranded DNA, plasmid pET-44a (+). For 
linearlized dsDNA, pET-44a (+) DNA was treated with 
restriction enzyme BamHI and XhoI and purified.
Finally, to generate DNA/RNA hybrid, firstly, sense 
ssRNA was transcribed from BamH I-linearized plas-
mid pcDNA3.1 (−) by T7 RNA polymerase. The runoff 
transcript (88 nucleotides) was treated with calf intes-
tine phosphatase (NEW ENGLAND BioLabs® INC), 
and end-labeled with γ-[p32] ATP by T4 polynucleotide 
kinase PNK enzyme (NEW ENGLAND BioLabs® INC). 




from Mission Biotech Company were mixed in 100 mM 
NaCl annealing buffer. Sample was heated to 80  °C for 
5 min and gradually cooled down to room temperature. 
The annealed samples was resolved on 8% acrylamide 
PAGE and double-stranded product was then isolated.
In vitro vhs assay using isotope labelled ss RNA and RRL 
translated vhs proteins
Firstly, Renilla Luciferase (R-Luc) RNA fragment was 
transcribed from p2LUC plasmid that was linearized 
with restriction enzyme BamH I by T7 RNA polymerase 
(Promega, USA) with α-[p32]-ATP incorporation for 2 h 
at 37  °C. Then, the 0.9 kb runoff transcript was purified 
with MicroSpin G-25 columns (GE Healthcare Life sci-
ence, USA).
For in  vitro vhs assay, R-Luc RNA substrates (3 ×  105 
counts per min) was incubated with RRL translated PrV 
vhs or only RRL(as a negative control) in vhs assay buffer 
(80  mM K+, 2  mM Mg2+, 0.25  mM ATP, 0.1  mM DTT, 
1.6 mM Tris–HCl, pH 7.8) at 37 °C. At the indicated time 
points (0, 15, 30  min), assay products were recovered by 
RNeasy® mini kit (QIAGEN, Center Mainz, Germany) 
and separated on a 1.3% formaldehyde agarose gel. All sig-
nals were transferred onto a Hybond-N+ membrane (GE 
Healthcare Bio-Science Corp., Piscataway, NJ, USA) and 
exposed to a phosphoimage screen (Fuji, Tokyo, Japan) and 
detected with a Bio-Imaging Analyzer (BAS-2500; Fuji).
In vitro vhs ribonuclease activity assay
Purified recombinant vhs proteins expressed from E. coli, 
or vhs proteins translated in rabbit reticulocyte lysate 
(RRL) were used in this study. In one reaction, 0.05 μg of 
ssRNA were incubated with 0.25 μg of NUS protein (as a 
negative control), or 0.25 μg of purified PrV vhs protein 
in vhs assay buffer (80  mM  K+, 2  mM  Mg2+, 0.25  mM 
ATP, 0.1 mM ATP, 0.1 mM DTT, 1.6 mM Tris–HCl, pH 
7.8) for the indicated time points. RNA reaction prod-
ucts were then analyzed by 1.3% agarose-formaldehyde 
gel electrophoresis and RNA quantity was measured by 
imageJ system.
For study the degradation pattern, and also to rule out 
residual endogenous RNase activity from E. coli, vhs 
translated from RRL was also used for RNA assay follow-
ing the method described previously [8]. Briefly, RNA 
substrates were produced and labeled with α-[p32] ATP 
by in  vitro transcription and then incubated with assay 
buffer (mock control), RRL reagent (negative control), 
or RRL translated vhs at 37  °C for the indicated time 
points (0, 15, 30 min). RNA products were recovered by 
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RNeasy® mini kit (QIAGEN, Center Mainz, Germany) 
and analyzed by 1.3% formaldehyde agarose gel electro-
phoresis and autoradiography image.
Northern blot analysis
Accumulation of reporter gene RNA was detected by 
Northern blot analysis using probe with sequences com-
plementary to R-luc. Briefly, R-luc probes were generated 
by PCR with primer set (Rluc-F: TCCGCTAGAGCC 
ACCATGAC and Rluc-R: GGCCCTTCACCTTCACG 
AAC). The PCR amplification conditions were 95  °C for 
5 min followed by 30 cycles of denaturation at 95 °C for 
1 min, annealing at 55 °C for 2 min, extension at 72 °C for 
2 min, and a final extension at 72 °C for 7 min. Radiola-
beled DNA probe was generated by random primer labe-
ling with α-[p32] dATP.
Total RNA was harvested from cells co-transfected 
with reporter plasmid pRluc and plasmid expressing 
wild type (WT) vhs (HSV-1, or PrV), or PrV vhs mutants 
with deletion of individual boxes by RNeasy® mini kit 
(QIAGEN). Subsequently, total RNA was separated on 
a 1.3% denaturing formaldehyde gel and transferred to 
a Hybond-N+ membrane (GE Healthcare Bio-Science 
Corp., Piscataway, NJ, USA). Following UV-crosslinking 
fixation and pre-hybridization (for 1  h at 68  °C in pre-
hybridization buffer 0.5  M sodium phosphate, 7% SDS 
and 1  mM EDTA), the membrane was hybridized with 
radiolabeled DNA probe at 68 °C overnight. After wash-
ing steps, the membrane was exposed to a phosphoimage 
screen (Fuji, Tokyo, Japan) and detected with a Bio-Imag-
ing Analyzer (BAS-2500; Fuji). The relative Rluc RNA 
level to mock control was plotted.
Luciferase reporter assays
The effect of PrV vhs on overall translation was evalu-
ated by luciferase reporter assays. Firstly, 293T cells 
were seeded on the day before transfection at a density 
of 1  ×  105 cells/well in a 24-well plate.  800  ng of vhs 
plasmids were co-transfected with 800  ng of construct 
expressing luciferase by Lipofectamine 2000® reagent 
(Invitrogen) according to the manufacturer’s instruc-
tions. Renilla luciferase expression was detected at 24 h 
post-transfection using a Dual-Glo luciferase assay sys-
tem (Promega) and measured by FLUOstar OPTIMA 
microplate reader (BMG Labtech, Offenburg, Germany).
Statistical analysis
All the results were conducted at least three independ-
ent repeats. Data was showed as mean ± SD. Pair t test 
was used to evaluate significant difference. The results 
of analysis were conducted by the GraphPad Prism5 sta-
tistical package analysis tool (GraphPad Software, San 
Diego, CA, USA). The p value less than 0.05 indicates the 
statistically significant difference and was shown asterisk 
sign (*) in all figures.
Results
In vitro assay of ribonuclease activity mediated by PrV vhs
Ribonuclease activity of a thioredoxin-PrV vhs fusion 
protein has been previously described; nevertheless, the 
vhs assay used involved the degradation of RNA markers 
in reaction buffer at high concentrations of NaCl (0.3 M) 
and imidazole (0.25 M) [16]. Taking this into considera-
tion, because the biochemistry properties of PrV vhs-
mediated enzyme activity still remains largely unknown, 
initially the nuclease activity of PrV vhs in the present 
study was measured following a well-established hydroly-
sis assay system [8, 18, 24]. To do this, the first step was 
to express and purify the PrV vhs protein using an E. coli 
expression system. A construct, pET44-PrV vhs, which 
has a NUS-tag sequence fused to the N-terminus region 
of PrV vhs was created and the structure of this expres-
sion plasmid is shown in Figure  2A. This plasmid was 
introduced into E. coli and expression of the recombinant 
PrV vhs protein was induced with IPTG (Figure 2B, lane 
2). This was followed by purification of the protein using 
Ni–NTA affinity chromatography (Figure 2B, lane 3). To 
avoid any unexpected effect on vhs activity caused by the 
NUS fusion tag, thrombin cleavage was conducted to 
remove this tag (Figure  2B, lane 4). The identity of PrV 
vhs was confirmed by Western blot analysis using hexa-
histidine antibody (Figure  2C), and also by mass spec-
trometry (data not shown).
The decay of single stranded (ss) RNA mediated by 
the PrV vhs protein was analyzed using NUS protein as 
the negative control. As is indicated in Figure  2D, the 
RNA was degraded in the presence of PrV vhs, while the 
same RNA was stable when treated with NUS protein. 
At 60-min incubation time with the PrV vhs, more than 
80% of the RNA present in the assay mixture had been 
degraded (Figure  2E), which indicates that the purified 
recombinant PrV vhs, on its own, did indeed harbors rib-
onuclease activity when using this assay.
Substrate specificity of PrV vhs mediated nuclease activity
Sequence alignment has indicated that the N-terminal 
and internal domains of the vhs protein share similarity 
with several cellular nucleases including the human Flap 
endonuclease (FEN-1), bacteriophage T4 RNase H and 
bacterial DNA polymerase I [24]. The substrates of these 
nucleases are not limited to ssRNA; hence, the nuclease 
activity of PrV vhs was investigated using different sub-
strates, namely various form of RNA (ssRNA, rRNA, 
mRNA), three forms of DNA (ssDNA, linear dsDNA, 
uncut dsDNA), and a DNA-RNA hybrid; this was car-
ried out in an in  vitro system. Similar to HSV vhs, PrV 
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vhs was found to degrade ssRNA and RNA with a cap 
and poly A tail structure (mRNAs). However, PrV vhs 
also was able to target rRNA for degradation, which is a 
significant difference from the activity profile of HSV-1 
vhs (Figure 3A). In contrast to the RNA substrates inves-
tigated, substrates consisting of DNA, including DNA/
RNA hybrid molecules, were resistant to the hydrolytic 
activity mediated by PrV vhs protein (Figures  3B and C).
The requirements for cofactors when RNase activity is 
mediated by PrV vhs
Ribonuclease activity is usually dependent on the pres-
ence of ions (Mg2+, K+) or an energy-generating compo-
nent (ATP or GTP) [7]. To date, the cofactors required 
for the PrV vhs-mediated decay has not yet been identi-
fied. To remedy this, experiments using a set of buffers 
consisting of different combinations of catalytic factors 
(Table  2) were set up to examine the effects of these 
cofactors on RNA degradation mediated by PrV vhs.
To increase the sensitivity of assay system, PrV vhs pro-
tein translated in RRL system (Figure  4A) was incubated 
with RNA substrates that had been internally labeled with 
a radioactive isotope α-[p32]. As shown by autoradiography 
in Figure 4B, degradation of RNA was obvious at 15-min 
post PrV vhs treatment, while RNA incubated with the 
RRL translation system alone (the mock control) remained 
unaffected throughout the time of the reaction (Figure 4B).
Next, in order to investigate what ions are necessary 
for activity, any residual salts carried over from the RRL 
translation system were depleted from either the RRL 
translation system itself or RRL translated vhs protein; 
this was done using a spin column (NAP 5, GE) followed 
by dialysis against assay buffer containing only Tris–HCl. 
The results show that, in the buffer deficient with all three 
catalytic factors (Mg2+, K+ or ATP), the desalted vhs pro-
tein (marked with an asterisk in Figure  4C) was unable 
to bring about RNA degradation (Figure  4C, buffer F). 
However, RNA degradation was restored when all three 
catalytic factors were added back into the assay system 
(Figure 4C, buffer D).
Subsequently, vhs RNA degradation was determined 
using three different buffers, B, E, and C, each of which 
lacked one of the three factors being tested, namely Mg2+, 
K+, or ATP, respectively. A lack of K+ or ATP alone did 
not affect the RNase activity of PrV vhs (Figure 4D, buffer 
E, and C, respectively). However, RNase activity was lost 
when Mg2+ was absent (Figure 4D, buffer B, lane 2), while 
supplementation with magnesium ions (+Mg 1 or 2 mM) 
restored the ability to degrade RNA (Figure  4D, buffer 
B, lane 4, 6). These findings indicate the importance of 
Mg2+ to PrV vhs activity.
Finally, assay buffers G, H, I, which contain only Mg2+, 
K+, or ATP, respectively, were used to explore whether 
any of these factors alone is sufficient in themselves for 
PrV vhs-dependent RNase activity. RNA degradation 
activity by desalted PrV vhs was not observed in buffer 
Figure 3 An in vitro assay of RNase activity mediated by PrV 
vhs using various substrates. (A) Different types of RNA, including 
single stranded RNA without cap (ssRNA), with cap and polyA tail 
(mRNA) and cellular total rRNA, were incubated with assay buffer 
(mock), recombinant vhs and the appropriate tag proteins, either NUS 
or Thioredoxin (THX) (negative control), for various times (as indicated 
above the gel). The degradation pattern was resolved by agarose 
electrophoresis. In addition to RNA, various DNA substrates (B) and a 
DNA‑RNA hybrid (C) were also tested.
Table 2 Various assay buffers used in this study.
A B C D E F
80 mM K+ + + + + − −
2 mM Mg2+ − − + + + −
0.25 mM ATP − + − + + −
0.1 mM DTT + + + + + +
1.6 mM Tris–HCl (pH 7.8) + + + + + +
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Figure 4 The catalytic factor requirements for RNase activity mediated by PrV vhs. Toincrease the sensitivity, PrV vhs was synthesized 
using the TNT® T7 Quick coupled Translation system (RRL) and simultaneously labeled with S35 (A). (B) Rabbit reticulocyte (RRL) translated PrV vhs 
protein displays ribonuclease activity in vitro. RNA internally labeled with α‑[P32]‑ATP was incubated with only assay buffer (mock control), RRL (as a 
vhs negative control), or in vitro translated PrV vhs at 37 °C for the indicated times (0, 15, and 30 min). The RNA reaction products were resolved by 
agarose gel electrophoresis followed by autoradiography. (C) Contribution of positive ions (e.g. Mg2+, K+) and ATP to PrV vhs mediated RNase activ‑
ity. To deplete the residual ions in RRL, desalted plain RRL or RRL translated vhs, as indicated by asterisks, were prepared using Sephadex G‑25 spin 
columns. The RNase activities of the desalted lysates were analyzed in assay buffer D or buffer F containing all, or none of the three factors (Mg2+, 
K+, ATP), respectively. To identify the requirements in terms of individual co‑factor for vhs‑dependent RNase activity, the RNA degradation activity 
of desalted PrV vhs was further analyzed in two systems: either using buffers missing one of the three co‑factors, namely buffers B, E, and C without 
Mg2+, K+, or ATP, respectively (D), or in buffers containing only one co‑factors (buffer F supplemented with Mg2+, K+, or ATP) (E). To confirm the 
contribution of Mg2+, the divalent chelator EDTA was added to the reaction containing Mg2+. Nuclease activity was measured using a Kodak image 
analyzer system and the amounts of RNA remaining (%) of three independent assays were plotted (F).
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F without any of the catalytic factors (Figure  4E, buffer 
F). The presence of Mg2+ alone was sufficient for RNase 
activity mediated by PrV vhs (Figure  4E, buffer F+ 
Mg2+), but no such effect was found for K+ or ATP alone 
(Figure 4E, buffer F+ K+, F+ ATP, respectively).
Furthermore, addition of EDTA, a divalent cation 
chelator, significantly inhibited the catalytic ability of 
PrV vhs in the presence of Mg2+ (Figure  4E, +EDTA 2 
or 4 mM). Overall, when the RNA remaining (%) under 
the various different assay conditions was compared, the 
results indicated that Mg2+ alone was able to allow the 
degradation of RNA substrates by PrV vhs, while, K+ and 
ATP alone were not sufficient for activity (Figure 4F).
The contribution to RNase activity of the four highly 
conserved functional boxes and the fourteen conserved 
residues found in PrV vhs
Based on the sequences alignment of the vhs proteins of 
the various α-herpesviruses, four conserved functional 
domains can be identified (Figure 1) and the location of 
these boxes on PrV vhs are illustrated in Figure 5A. Up 
to now the contribution of these four boxes to PrV vhs-
induced RNase activity has remained unclear. Therefore, 
an in  vitro a reporter assay, modified from a previous 
study [25], was set up to determine PrV vhs-dependent 
ribonuclease activity using six constructs. The constructs 
express the wild type vhs protein of HSV-1 as a posi-
tive control, the wild-type PrV as a second control and 
the four proteins with individual deletions of the four 
conserved boxes within PrV vhs. The effects of these 
deletions of the vhs protein on RNA degradation were 
evaluated by co-transfected each construct with a lucif-
erase reporter plasmid in order to measure the loss of 
luciferase mRNA.
Luciferase activity in cells co-expressing the wild-
type viral vhs proteins from either HSV-1 or PrV was 
significantly lower than the luciferase activity in the 
control cells transfected with an empty expression vec-
tor (pcDNA3.1) (Figure  5B). The decrease in luciferase 
activity was correlated with the amount of reporter 
RNA present in the transfected cells based on Northern 
blot analysis (Figure  5C). When the four vhs mutants 
were compared to the wild type PrV in this system, both 
reporter enzyme activity and RNA level were greatly 
elevated compared to the cells expressing wild-type vhs. 
These findings indicate that all four predicted conserved 
boxes seem to contribute to PrV vhs-dependent RNA 
degradation.
Figure 5 The contribution of conserved functional domains to vhs-dependent RNase activity. The locations of the four boxes (I–IV) in PRV 
vhs are presented (A). Constructs with deletions of one of the PrV vhs boxes were generated and co‑transfected with plasmid expressing luciferase 
in human 293T cells. Cells transfected with empty vector (pcDNA3.1) or HSV‑1 vhs (HSV‑1) served as negative and positive controls, respectively. 
The effects of the individual boxes were evaluated using this in vivo system (luciferase reporter assay). The luciferase activities of three independent 
assays were plotted (B). In addition, the RNA level of the reporter gene was also monitored by Northern blot analysis (upper panel in C). A loading 
of total RNA of 10 μg per gel lane was used.
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Sequence alignment and the effect of mutation of various 
highly conserved residues within the PrV vhs protein 
on RNase activity
The specific sequences that contribute to the RNase 
activity of HSV-1 vhs have been identified. However, in 
this regard, little is known about PrV vhs. Despite the 
difference in size of the two proteins (489 vs. 365 resi-
dues) and the low sequence similarity between HSV-1 
vhs and PrV vhs (Figure  1), several functionally signifi-
cant residues located within the active site (Boxes I-III) 
are conserved in PrV vhs (as indicated by the arrowheads 
in Figure 1), including D34, D82, K96, E192, D194, T211, 
D213, D215, and D261, as well as amino acid 214. The 
first seven key amino acids have been shown to be critical 
to both nuclease activity in general and to the ribonucle-
ase activity of HSV-1 vhs (as summarized in Table 3); this 
was determined using a combination of genetic and bio-
chemical approaches [24]. Importantly, residue 214 is a 
vhs activity determinant and a HSV-1 mutant (vhs1) har-
boring a point mutation at residue 214 (Thr214 → Ile) in 
the UL41 coding region results in complete abolishment 
of vhs activity [26, 27]. The coordinate position of T214 
on PrV vhs is residue T172.
It is worth noting that the above predicted functional 
important residues are located near the N-terminal 
(residues 1–103 within Box I and Box II) and within an 
internal region (residues 165–265 within Box III) of the 
HSV-1 vhs coding region (Figure  1). Furthermore, in 
addition to these positions, an additional four amino 
acids (P343, P345, L352 and W356), which are found 
in functional Box IV, are conserved across members of 
α-herpesviruses, including HSV-1, HSV-2 and PrV. To 
define the contribution of all of the above residues to 
PrV activity, we altered each of the corresponding four-
teen residues in the PrV vhs (D34, D81, K95, E150, D152, 
D169, D171, D172, D173, D219, P343, P345, L352, and 
W356) to alanine by site-directed mutagenesis using the 
primers listed in Table 1.
The effect of these mutations on PrV vhs activity was 
then investigated by Luciferase reporter assay. Among 
these fourteen conserved residues, mutations at residues 
34, 81, 95, 150, and 219 did not affect the ribonuclease 
activity mediated by PrV vhs (Figure  6A); while point 
mutation at D152, D169, D171, D172, D173, P343, P345, 
L352, and W356 did significantly reduce the vhs activity 
detected.
Discussion
To date, the HSV-1 vhs protein has been well charac-
terized, however little is known about the bioactivity 
of the PrV vhs protein. Previously, the RNase activ-
ity of PrV vhs was identified using standard RNA 
Table 3 Impact of the fourteen highly conserved residues on activity of HSV-1 vhs protein and other nucleases.
“−” indicates the point mutations lost RNase activity and the ability of Mg2+  or eIF4H binding.
“<” indicates the point mutations partially reduced RNase activity and the ability of Mg2+  binding.
“N” indicates the impact of those residues have not yet been defined.






















D34 D34 − − + D19 − − D34 − −
D81 D82 − − + D71 − − D86 − −
K95 K96 − − N K87 N − R103 N +
E150 E192 − − + E130 N N E158 − −
D152 D194 − − + D132 − − E160 − N
D169 T211 − < − S153 − < T177 N N
D171 D213 − − + D155 − − D179 − +
D172 T214 − − − D156 N N D180 N N
D173 D215 − − + D157 − ≪ D181 − ∓
D219 D261 − < + D200 − + D233 − −
P343 P465 N N − − N N E357 N N
P345 P467 N N − − N N E359 N N
L352 L474 N N − − N N K366 N N
W356 W478 N N − − N N G370 N N
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markers, and a recombinant vhs-thioredoxin fusion 
protein in buffer containing very high concentrations 
of imidazole and NaCl. This implies that there might 
be problems associated with the possible effects of salt, 
the bulky thioredoxin tag (with size of ~20  kDa) and 
intrinsic RNase activity contamination. Furthermore, 
cofactor requirements, such as Mg2+ and/or ATP, were 
not considered [16]. This motivated us to further char-
acterize the ribonuclease activity of PrV vhs in more 
depth.
Accumulating evidence has suggested that the vhs pro-
tein serves as an endoribonuclease or a component of a 
ribonuclease complex [9, 11, 12]. To define the role of 
vhs, a soluble protein purified to homogeneity is neces-
sary; however this was jeopardized by the poor solubility 
of native vhs. In 2006, HSV vhs itself was proved to be 
an RNase for the first time using GST-tagged vhs puri-
fied under native condition with a lower concentration 
of detergent [28]. In a similar manner, in order to avoid 
the insolubility issue, PrV vhs was expressed as a fusion 
protein with a NUS-tag in the present study. As shown 
in Figure  2B, the improved solubility and yield (lane 2) 
allowed purification of the recombinant PrV vhs protein 
to a high homogeneity with ease (lane 3), and thereby 
residual RNase contamination from E. coli was mini-
mized. Since, addition of a fusion peptide can be detri-
mental to vhs RNase activity, the NUS tag (~70  kDa), 
which was added at the N-terminal of the recombinant 
PrV vhs, was removed as part of the present study. The 
RNase activity of PrV vhs was confirmed by an in  vitro 
RNA hydrolytic assay following the method established 
by other research groups [17, 18]. To further exclude the 
possible contamination with unwanted RNase activity 
from proteins expressed in E. coli or other sources, the 
RNase inhibitor, RNaseOUT®, was constantly included 
in the assay, and vhs translated using the RRL system was 
also used in this study. It is worth noting that the vhs-
dependent RNase is resistant to this RNase inhibitor [7, 9, 
12, 18], while another study using recombinant GST-vhs 
expressed from E. coli indicated that HSV-1 vhs nuclease 
activity is blocked by an RNase inhibitor [28]. Using the 
PrV vhs, significant RNase activity was observed in the 
presence of an RNase inhibitor, indicating that activity of 
PrV vhs is not affected by the RNase inhibitor.
The ribonuclease activity of PrV vhs resembles that 
of HSV vhs; nevertheless, the biochemical character-
istics of these two proteins are not identical. They both 
require Mg2+ and target mRNA for degradation. Lu et al., 
reported that the vhs of HSV-1 produced from yeast 
displayed little if any vhs-dependent RNase activity and 
seemed to require one or more mammalian cellular fac-
tors for efficient activity [9]. In our study, the purified 
recombinant PrV vhs protein did exhibit RNase activ-
ity without the aid of other proteins. Moreover, unlike 
HSV-1 vhs, PrV vhs is able to degrade not only mRNA, 
but also rRNA and ss RNA without a cap and polyA tail 
using an in  vitro assay system. Of note, in the reporter 
assay, rRNA level was not significantly affected by PrV 
vhs in transfected cells (as shown on the agarose gel in 
Figure  5C). Reporter assay resembles to an in  vivo sce-
nario in which rRNAs are associated with a number of 
ribosomal proteins, while ribonuclease assay is an in vitro 
system of which rRNA substrate was extracted by phe-
nol-based reagent that degrades proteins and renders 
rRNA unprotected. Hence, rRNA with or without cel-
lular protein association is likely the cause of ambiguous 
findings in two systems.
The amino acid sequences of vhs orthologs of 
alphaherpesviruses share similarity with a number 
of nucleases from various organisms, including flap 
endonuclease 1 (FEN-1) and RNase H [24]. FEN-1 is a 
structure-specific nuclease that participates in DNA 
metabolic pathways [29], and RNase H removes RNA 
in a DNA/RNA duplex substrate. Stevens demonstrated 
Figure 6 Contribution of the fourteen conserved residues 
present in PrV vhs to RNase activity in vivo. Reporter plasmid, 
pRluc (encoding Renilla luciferase) was co‑transfected with each 
one of the vhs constructs into human 293T cells. The effect of each 
vhs protein on reporter gene expression was evaluated based on 
luciferase activity. HSV‑1 vhs (HSV) served as a positive control for 
PrV vhs‑dependent RNase activity. The luciferase activities of three 
independent assays were plotted (A). A structure indicating the key 
residues of PrV vhs surrounding the Mg2+ in the protein was created 
by simulation (B).
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that, in addition to DNA, the FEN-1 nuclease also is able 
to cleave a cap-independent RNA substrate at 20% of 
the rate of DNA substrates when Mg2+ is present [30]. 
Based on these similarities, an attempt was made to 
explore whether PrV vhs is able to function as a DNase. 
It appears that various DNA molecules, including both 
single stranded and double stranded forms, are not a 
substrate of PrV vhs (Figure  3B). Notably, when uncut 
plasmid was included in the assay, compared with the 
control group, incubation of PrV vhs yields an extra 
banding with faster mobility (indicated by asterisks). 
However, whether it is a cleaved fragment of dsDNA or 
another type of dsDNA entity with a different conforma-
tion that is generated by the action of PrV vhs requires 
further investigation.
It is obvious that, within the highly homologous 
regions of the vhs protein, there are several active-site 
residues of nucleases that are conserved (Table 3). In cur-
rent study, amino acids 152,169,171,172,173, 343, 345, 
352 and 356 were found to be important for PrV vhs 
ribonuclease activity (Figure 6A). Among these residues, 
PrV vhs T172, which corresponds to T214, was identi-
fied as a key activity determinant of HSV-1 vhs based on 
the findings obtaining with a HSV-1 mutant virus, vhs1 
[26, 27]. D34, D82, K96, E192, D194, T211, D213, D215 
and D261 are conserved functional residues in HSV-1 
vhs, and it has been shown that changing these abrogates 
vhs functioning [12, 13, 23, 24, 31–36]. However, not all 
of these amino acids are critical to PrV vhs functional-
ity and mutations of only four residues, namely. D152, 
T169, D171, and D173, reduced vhs activity in an in vivo 
reporter assay. Structure simulation suggests that D152, 
T169, D171, and D173 may be located either in the 
active site within the protein or in close proximity to the 
binding site for the catalytic metal ions (Mg2+), both of 
which are very important to vhs-induced RNase activity 
(Figure 6B).
It is worth noting that the nine key amino acids believed 
to be related to HSV-1 vhs dependent RNase activity 
were initially predicted based on the structure similar-
ity of vhs with other cellular nuclease [24], and are found 
in the N-terminal and internal region of HSV-1 vhs. This 
means that the impact on vhs activity of residues located 
in C-terminus has not been explored up to now. In the 
present study we have shown that four additional amino 
acids (P343, P345, L352 and W356) that are found within 
the predicted Box IV are completely conserved across 
members of α-herpesviruses (HSV-1, HSV-2, VZV, EHV, 
PrV) [15]. When a similar analysis to the other conserved 
amino acids was carried out on these amino acids, it was 
found that these also contribute to PrV vhs activity. Pre-
vious studies have demonstrated that the C-terminus of 
HSV vhs is involved in the interaction of vhs with eIF4H 
[12]. Page and Read identified that a deletion of as few as 
108 amino acids from the C terminus of HSV-1 vhs is suf-
ficient to hinder vhs binding to eIF4H, but not to eIF4A 
II [13]. Hence, it is possible that mutants at residues 343, 
345, 352 and 356 in PrV vhs obstruct interaction of the 
protein with other cellular factors (e.g. eIF4H) and conse-
quently this affects RNA degradation activity. Neverthe-
less, whether these cellular factors play an important role 
in PrV vhs activity remains unclear and requires further 
investigation.
In conclusion, we have characterized the nuclease 
activity of the PrV vhs protein using both in  vitro and 
in vivo systems. The enzyme is similar to, but not identi-
cal to, HSV-1 vhs. The activity of PrV vhs requires Mg2+, 
but does not require either K+ or ATP. The enzyme is 
resistant to an RNase inhibitor. Furthermore, the enzyme 
degrades not only mRNA, but also rRNA. Despite the 
low sequence similarity between PrV vhs and other vhs 
proteins, some, but not all, of the conserved residues 
critical for HSV-1 vhs RNase activity are essential for PrV 
vhs RNase activity.
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